Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "HealthTech"


25 mentions found


The behemoth health-records company Epic, which touches all corners of the healthcare ecosystem, is embracing generative AI as a necessary priority. For eight months, he and a team at Microsoft have been working with OpenAI to explore how generative AI could work in healthcare. Scientific, ethical, and legal mysteries behind ChatGPTLee's panel drew top leaders from tech and healthcare, and their questions on generative AI were sweeping. OConnor edited the note to fix a mistake and clicked a button to transfer it directly into the patient's health record. Generative AI is far from a slam dunk, HIMSS's Bogdan said, citing adoption and privacy concerns.
But with increasing patient demand and complexity, there are not enough doctors in the healthcare system to match that level of care, he said. With its promise of free universal healthcare, the UK's National Health Service has long been a source of national pride. A growing number of clinicians are becoming "doctorpreneurs," applying their first-hand experience in healthcare to build startups to help fill that gap. As clinicians in the UK expand their startups abroad, they predict the doctorpreneur trend will become a global phenomena — with health startups in other countries looking to the UK for inspiration. Selim noted that many doctors — across continents — are also incentivized by a unifying mission, which is to offer patients hope.
Insider has identified 12 digital-health startups that are M&A targets in 2023 with Dealroom data. Dealmaking remains strong among healthtech startups in the region, which recorded $13.27 billion in M&A exits in 2022 across 546 deals, according to PitchBook data. Insider has used data from Dealroom to analyze potential M&A targets in the digital-health sector. The criteria used on Dealroom's platform are not exhaustive but are a data-centric approach to looking at some potential targets. Here is a list of the 12 digital-health startups that could be scooped up as investors flock to the M&A market.
She worked for two years in a remote job, while living in Greece, Portugal, Germany, and Argentina. I quit my job with no planI quit my job in July 2019 with nothing lined up. I got a remote job as the head of marketing for a recruitment-tech startup. I had savings from working in my marketing job. I quit my remote job in August 2021 and left Madeira.
Silicon Valley Bank was shut down by US regulators on Friday. It's been a chaotic day for the startup world following the failure of Silicon Valley Bank. Insider spoke with eight startup founders about how they're responding to the crisis. Other founders weren't as fortunate: They still had their company's funds at Silicon Valley Bank as the FDIC announced it had taken control of the bank. A couple of early-stage founders told Insider they did not hold accounts with Silicon Valley Bank.
Silicon Valley Bank's collapse has left hundreds of startups facing a cash crunch and payroll crisis. It leaves hundreds of startups that deposited their cash with the bank in turmoil, as they try to continue operating while millions in funds are locked up. Startups scramble for cashThe need for startups to make payroll is one being echoed across the VC ecosystem. In a tweet, founder Nikita Bier said: "The number of growth stage companies that had their cash at SVB is huge. Even startups that didn't bank directly with SVB have been hit by its collapse.
Silicon Valley Bank was shut down by regulators on Friday. The news has made startup founders worried that they won't be able to pay their employees next week. Startup founders still reeling from Silicon Valley Bank's implosion have something new to stress about: whether they'll be able to access enough money to cut employee paychecks next week. "Lots of startups are missing payroll in 2-4 weeks if a) Silicon Valley Bank doesn't have the deposits b) SVB doesn't get sold or c) SVB isn't rescued." "If you're a startup founder dealing with this, I'm here to help any way I can," Ayush Sharma, founder and CEO of payroll and compliance startup Warp, tweeted.
Europe's mental health startups raised a record $1.4 billion in 2021 but investment slumped last year. We asked 9 of Europe's top mental health VCs to name the startups to watch in 2023. Startups tackling issues around mental health have been far from immune to the global slowdown in tech funding. Insider asked nine European venture capitalists to pick out mental health startups that will excel throughout 2023 despite the overarching slowdown in funding. Here are 15 European mental health startups to watch in 2023, according to some of the region's top investors.
A new wave of startups are tackling financial issues within the healthcare space. Here are 14 fintech-healthtech startups that have raised money from VCs. "If you're thinking about building fintech that really helps the average consumer, a big piece of the wallet is healthcare spend," she told Insider in an interview. From the employee-benefits platform Budgie to the wellness credit card Ness, Insider has compiled a list of startups building at the intersection of fintech and healthtech. Check out Insider's list of 14 startups at the intersection of fintech and healthtech.
Herrod, the former CTO of VMWare, will build enterprise startups in areas like AI and cybersecurity. Herrod is joining the venture studio Juxtapose, where he will focus on creating enterprise software startups, he told Insider exclusively. Though Juxtapose's portfolio includes a range of industries such as fintech, insurance, and healthtech, the firm hasn't had a long reach within enterprise software. He told Insider he sees ample opportunity within segments such as cybersecurity, open-source software, software supply-chain management, and artificial intelligence — several of which are receiving a hefty amount of attention from VCs right now. Now the venture world is full of former tech executives who have made the switch to backing startups.
NOCD in January raised $34 million as digital-health funding tumbles. In a brutal time to raise money from investors, the mental-health startup NOCD, which provides care for people with obsessive-compulsive disorder, just raised $34 million. Cigna Ventures, the health-insurance giant's venture-capital arm, and 7wireVentures, a prominent healthtech venture-capital firm, co-led the round, bringing NOCD's total funding to $84 million. NOCD shared with Insider the presentation that helped it land $34 million from Cigna Ventures and 7wireVentures. Here's the deck NOCD used to raise $34 million from top investors.
The startup Wally Health provides dental cleanings and preventative care for $199 a year. Take a look at the pitch deck Wally used to raise a $3 million seed round led by Bling Capital. That experience inspired the creation of his startup, Wally Health, which has raised $3 million in a seed round led by Bling Capital. Years before Wally, Burnett had launched businesses in media and fintech back in his native Canada. After raising a pre-seed round, Burnett and his cofounders started building Wally's proof of concept about a year ago in an office in New York's Upper East Side.
Vial's CEO asked workers to post positive Glassdoor reviews to counter negative ones, Insider found. In a month, 20 positive reviews for Vial flooded the site, raising its rating from one to 3.8 stars. On December 12, Simon Burns, a cofounder and the CEO of the healthtech startup Vial, sent a Slack message in his company's "random-kudos" channel. He included a link to Vial's Glassdoor page and asked other employees to "give her a hand, review us on Glassdoor." In earlier days at the startup, negative employee reviews on Glassdoor cited a toxic culture, a disconnected leadership team, and a lack of industry experience.
Vial let go of its entire site network division, 40 to 50 people, last October, Insider has learned. Just a month after the October cuts, the healthtech startup announced a $67 million funding round. Ahead of the deluge of tech layoffs that have plagued the beginning of 2023, one healthtech startup quietly slashed dozens of jobs late last year, Insider has learned. In October, Vial, which helps biotech companies run faster and more efficient trials, laid off an entire division. As of December 2022, Vial had 125 employees, according to Pitchbook.
Despite a tumultuous market for startup investing, VCs still landed top deals at hot startups. Behind these successes were the smart and savvy rising-star VCs working to transform the industry. Here are some of the rising stars of venture capital who are names to watch in 2023. Insider asked the VCs we named in last year's rising-stars list and the general public to nominate this year's most promising venture investors. For instance, OMERS Ventures' Chrissy Farr made the jump to healthtech investing after working as a journalist covering the venture industry for CNBC.
A VC downturn is upon us, but healthtech founders will still have opportunities to raise capital. Healthcare founders at Salvo Health, Parallel Learning, and other startups raised money in 2022. 11 healthtech founders told Insider their best pieces of pitch-deck advice. "We need to invest in consumer-first experiences within the healthcare system that will ultimately lead to better outcomes." Insider spoke with 11 healthcare founders who collectively raised more than $146 million from investors in 2022.
The market downturn will create opportunities for more M&A, Devin Carty, the CEO of Martin Ventures, saysDevin Carty. Martin VenturesIf 2021 was the year of big venture checks and wildly oversize valuations among healthcare startups, 2022 was when it all came crashing back to earth. But the down economy will be an opportunity for venture-capital and private-equity firms, said Carty. His Nashville, Tennessee, venture-capital firm invests in and launches healthcare startups, including companies transforming primary care, such as Wellvana, or kidney care, such as Evergreen Nephrology. So far in 2022, the firm invested in six new companies and nine startups already in its portfolio.
VCs poured $13.5 billion into healthtech startups in 2022 — down nearly 50% from 2021. But a global slump and the tech downturn changed all of that, and funding into health startups fell by nearly 50% to $13.5 billion this year. AI-driven drug development and mental health startups also boomed during COVID-19 but have seen a funding dropoff in 2022. Tech that served underrepresented groups was spotlightedFrom menopause to mental health, health conditions that were billed as 'taboo' pre-pandemic have come to the forefront this year. Startups offering personalized treatments for niche issues or demographics, such as menopause app Vira Health, mental health platform MyMynd, and men's health platform Numan, all raised capital this year.
For startup founders and venture capitalists, the office holiday party is a December tradition. For many venture capitalists and the startup founders they invest in, December is synonymous with two things: end-of-year paperwork and office holiday parties. But this year, holiday parties in startup-land look a little different. "Align those goals with your holiday party, and you can do something powerful and cost-effective," she said. "You should maybe cut some travel, maybe you don't have a big holiday party, but that's all drop in the bucket compared to head count," he said.
The market downturn will create opportunities for more M&A, Devin Carty, the CEO of Martin Ventures, saysDevin Carty. Martin VenturesIf 2021 was the year of big venture checks and wildly oversize valuations among healthcare startups, 2022 was when it all came crashing back to earth. But the down economy will be an opportunity for venture-capital and private-equity firms, said Carty. His Nashville, Tennessee, venture-capital firm invests in and launches healthcare startups, including companies transforming primary care, such as Wellvana, or kidney care, such as Evergreen Nephrology. So far in 2022, the firm invested in six new companies and nine startups already in its portfolio.
The sustainable-healthtech startup Cabinet Health just raised $17 million from Global Impact Fund. Check out the pitch deck Cabinet Health used to land its latest round of funding. Cabinet Health just raised millions of dollars in new capital for its mission to make medication refills more earth-friendly. Cabinet Health was founded in 2018 with the goal of eliminating single-use plastics from the pharmaceutical industry. Check out the 16-slide pitch deck Cabinet Health used to raise its most recent round of funding:
Over 150,000 tech workers have lost their jobs in 2022, according to tracker site Layoffs.fyi. More than 150,000 tech workers have lost their jobs this year, according to data from tracker site Layoffs.fyi. Industries that grew rapidly during the pandemic — such as health tech, education tech, and crypto — have been the worst affected in 2022. The issue, he said, was that some investors in crypto, education tech, and health tech paid little heed to economic fundamentals. Amid recessions, B2B sub-sectors such as corporate education tech and employee coaching remain promising pockets within education tech, the investor added.
The share of US workers who have access to family leave, including parental leave, is increasing. Like many women, Amanda Krupa took less parental leave than she was allowed in order to protect her career and income. The rate of women taking maternity leave hasn't changed since the '90sThe US is the only industrialized country that doesn't guarantee paid parental leave. Some employers offer short-term-disability insurance to help cover workers' parental leave, but it doesn't always replace all wages. Today, all employees there are eligible for 16 weeks of paid parental leave.
Drug discovery startups bagged a record $5.5 billion globally in 2021, per Dealroom data. Startups are innovating ways to speed up the expensive and time-consuming process of drug discovery. Investor appetite peaked as the pandemic highlighted the need for efficient approaches to drug discovery, from shorter clinical trial times to quicker avenues to mass distribution. Daniel noted that healthtech VCs are particularly keen to back drug discovery startups that have a sound network of advisors. "There will be lots of players out there and we'll probably see a lot of aggregation in the coming years," Daniel told Insider.
Komodo Health has ditched its plans for an initial public offering in the near future. Digital health's IPO desertGlobally, only six digital health companies have gone public via IPO in 2022 so far, according to a report by Galen Growth and Finn Partners. Besides Komodo, two other digital health companies were said to be pursuing an IPO earlier this year before the market slipped. "The IPO market is shut right now, for all intents and purposes," said Jon Swope, who leads SVB Securities' digital health and healthtech business. "How soon will we see the return of that for the IPO market?"
Total: 25